JB Hunt Trans Financials

JBHT

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 42/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

JB Hunt Trans has an operating margin of 6.9%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 34/100, indicating healthy but not exceptional operating efficiency. This is down from 7.7% the prior year.

Growth

JB Hunt Trans's revenue declined 5.8% year-over-year, from $12.8B to $12.1B. This contraction results in a growth score of 12/100.

Leverage

100

JB Hunt Trans carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

JB Hunt Trans's current ratio of 1.06 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

JB Hunt Trans's free cash flow margin of 5.1% results in a low score of 26/100. Capital expenditures of $865.4M absorb a large share of operating cash flow.

Returns

JB Hunt Trans's ROE of 14.2% shows moderate profitability relative to equity, earning a score of 57/100. This is down from 17.8% the prior year.

Altman Z-Score Safe

5.97

JB Hunt Trans scores 5.97, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

JB Hunt Trans passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.60x

For every $1 of reported earnings, JB Hunt Trans generates $2.60 in operating cash flow ($1.5B OCF vs $570.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

10.5x

JB Hunt Trans earns $10.5 in operating income for every $1 of interest expense ($831.2M vs $79.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

This page shows JB Hunt Trans (JBHT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$12.1B

YoY-5.8%

5Y CAGR+5.7%

10Y CAGR+7.0%

JB Hunt Trans generated $12.1B in revenue in fiscal year 2024. This represents a decrease of 5.8% from the prior year.

EBITDA

$1.6B

YoY-8.0%

5Y CAGR+5.2%

10Y CAGR+5.6%

JB Hunt Trans's EBITDA was $1.6B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 8.0% from the prior year.

Free Cash Flow

$617.8M

YoY+624.4%

5Y CAGR+20.4%

JB Hunt Trans generated $617.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 624.4% from the prior year.

Net Income

$570.9M

YoY-21.6%

5Y CAGR+2.0%

10Y CAGR+4.3%

JB Hunt Trans reported $570.9M in net income in fiscal year 2024. This represents a decrease of 21.6% from the prior year.

EPS (Diluted)

$5.56

YoY-20.2%

5Y CAGR+3.1%

10Y CAGR+5.8%

JB Hunt Trans earned $5.56 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 20.2% from the prior year.

Cash & Debt

$47.0M

YoY-11.9%

5Y CAGR+6.1%

10Y CAGR+22.9%

JB Hunt Trans held $47.0M in cash against $977.7M in long-term debt as of fiscal year 2024.

Dividends Per Share

$1.72

YoY+2.4%

5Y CAGR+10.6%

10Y CAGR+8.0%

JB Hunt Trans paid $1.72 per share in dividends in fiscal year 2024. This represents an increase of 2.4% from the prior year.

Shares Outstanding

101M

YoY-2.6%

5Y CAGR-1.1%

10Y CAGR-1.5%

JB Hunt Trans had 101M shares outstanding in fiscal year 2024. This represents a decrease of 2.6% from the prior year.

Gross Margin

N/A

Operating Margin

6.9%

YoY-0.9pp

5Y CAGR-1.1pp

10Y CAGR-3.4pp

JB Hunt Trans's operating margin was 6.9% in fiscal year 2024, reflecting core business profitability. This is down 0.9 percentage points from the prior year.

Net Margin

4.7%

YoY-1.0pp

5Y CAGR-0.9pp

10Y CAGR-1.4pp

JB Hunt Trans's net profit margin was 4.7% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.0 percentage points from the prior year.

Return on Equity

14.2%

YoY-3.5pp

5Y CAGR-8.6pp

10Y CAGR-16.9pp

JB Hunt Trans's ROE was 14.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 3.5 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$513.9M

YoY+222.1%

5Y CAGR+13.3%

10Y CAGR+15.2%

JB Hunt Trans spent $513.9M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 222.1% from the prior year.

Capital Expenditures

$865.4M

YoY-53.5%

5Y CAGR+0.3%

10Y CAGR+0.7%

JB Hunt Trans invested $865.4M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 53.5% from the prior year.

JBHT Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$12.1B-5.8%	$12.8B-13.4%	$14.8B+21.7%	$12.2B+26.3%	$9.6B+5.1%	$9.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$306.4M+11.6%	$274.6M+27.5%	$215.4M+10.1%	$195.6M+8.6%	$180.1M-6.2%	$191.9M
Operating Income	$831.2M-16.3%	$993.2M-25.4%	$1.3B+27.4%	$1.0B+46.6%	$713.1M-2.8%	$733.8M
Interest Expense	$79.0M+19.8%	$65.9M+28.7%	$51.2M+10.8%	$46.3M-2.8%	$47.6M-13.0%	$54.7M
Income Tax	$188.6M-8.7%	$206.6M-33.8%	$312.0M+30.6%	$239.0M+49.4%	$160.0M-2.8%	$164.6M
Net Income	$570.9M-21.6%	$728.3M-24.9%	$969.4M+27.4%	$760.8M+50.3%	$506.0M-2.0%	$516.3M
EPS (Diluted)	$5.56-20.2%	$6.97-24.3%	$9.21+29.0%	$7.14+50.6%	$4.74-0.6%	$4.77

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$3.1B+4.3%	$2.9B+0.2%	$2.9B-7.1%	$3.1B+7.4%	$2.9B-0.5%	$2.9B-10.9%	$3.3B+4.4%	$3.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$69.0M-7.8%	$74.9M+2.6%	$73.0M-11.5%	$82.5M+10.4%	$74.7M-2.7%	$76.8M-7.8%	$83.3M+20.0%	$69.4M
Operating Income	$242.7M+23.0%	$197.3M+10.4%	$178.7M-13.7%	$207.0M+0.6%	$205.7M+5.8%	$194.4M-4.4%	$203.3M-15.9%	$241.7M
Interest Expense	$17.9M-16.0%	$21.3M+14.5%	$18.6M-17.1%	$22.4M+11.0%	$20.2M+29.1%	$15.6M-34.7%	$24.0M+90.3%	$12.6M
Income Tax	$53.9M+13.9%	$47.4M+11.9%	$42.3M+16.1%	$36.5M-26.5%	$49.6M-3.1%	$51.2M+53.3%	$33.4M-19.9%	$41.7M
Net Income	$170.8M+32.8%	$128.6M+9.2%	$117.7M-24.3%	$155.5M+14.4%	$135.9M+6.6%	$127.5M-17.0%	$153.5M-18.1%	$187.4M
EPS (Diluted)	$1.76+34.4%	$1.31+12.0%	$1.17-23.5%	$1.53+15.9%	$1.32+8.2%	$1.22-17.0%	$1.47-18.3%	$1.80

JBHT Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$8.3B-3.2%	$8.6B+10.3%	$7.8B+14.6%	$6.8B+14.6%	$5.9B+8.4%	$5.5B
Current Assets	$1.8B-9.7%	$2.0B-11.3%	$2.2B-4.4%	$2.3B+25.6%	$1.8B+24.4%	$1.5B
Cash & Equivalents	$47.0M-11.9%	$53.3M+2.7%	$51.9M-85.4%	$355.5M+13.5%	$313.3M+795.1%	$35.0M
Inventory	$41.7M-1.2%	$42.2M+3.9%	$40.6M+62.2%	$25.0M+5.2%	$23.8M+12.8%	$21.1M
Accounts Receivable	$1.2B-8.3%	$1.3B-12.6%	$1.5B+1.4%	$1.5B+34.0%	$1.1B+11.1%	$1.0B
Goodwill	N/A	N/A	N/A	$100.5M-4.6%	$105.4M+9.4%	$96.3M
Total Liabilities	$4.3B-4.2%	$4.5B+8.8%	$4.1B+12.1%	$3.7B+10.5%	$3.3B+3.9%	$3.2B
Current Liabilities	$1.7B+15.5%	$1.5B-7.4%	$1.6B-9.3%	$1.7B+59.4%	$1.1B+4.7%	$1.0B
Long-Term Debt	$977.7M-26.3%	$1.3B+5.1%	$1.3B+33.5%	$945.3M-27.6%	$1.3B+0.7%	$1.3B
Total Equity	$4.0B-2.2%	$4.1B+11.9%	$3.7B+17.6%	$3.1B+19.9%	$2.6B+14.7%	$2.3B
Retained Earnings	$7.4B+5.7%	$7.0B+8.6%	$6.4B+14.3%	$5.6B+12.8%	$5.0B+8.5%	$4.6B

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$8.1B-1.6%	$8.2B-0.2%	$8.3B-0.7%	$8.3B-1.2%	$8.4B-0.1%	$8.4B-1.9%	$8.6B+2.6%	$8.4B
Current Assets	$1.7B-0.6%	$1.7B+1.0%	$1.7B-5.7%	$1.8B-7.5%	$1.9B-1.8%	$1.9B-0.6%	$2.0B-0.5%	$2.0B
Cash & Equivalents	$52.3M+2.7%	$50.9M+17.3%	$43.4M-7.6%	$47.0M-12.2%	$53.5M-16.6%	$64.2M+20.3%	$53.3M-29.1%	$75.2M
Inventory	N/A	N/A	N/A	$41.7M	N/A	N/A	$42.2M	N/A
Accounts Receivable	$1.2B+4.2%	$1.2B-1.7%	$1.2B-1.7%	$1.2B-2.2%	$1.3B-1.6%	$1.3B-4.7%	$1.3B-2.6%	$1.4B
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.5B-1.1%	$4.6B+4.5%	$4.4B+2.1%	$4.3B-1.0%	$4.3B+1.8%	$4.3B-5.0%	$4.5B+3.0%	$4.4B
Current Liabilities	$1.9B0.0%	$1.9B+3.1%	$1.9B+11.7%	$1.7B+6.1%	$1.6B+2.4%	$1.5B+6.3%	$1.5B-18.4%	$1.8B
Long-Term Debt	$902.2M-11.5%	$1.0B+15.9%	$880.2M-10.0%	$977.7M-34.1%	$1.5B+8.6%	$1.4B+3.0%	$1.3B+10.9%	$1.2B
Total Equity	$3.6B-2.3%	$3.7B-5.5%	$3.9B-3.7%	$4.0B-1.5%	$4.1B-2.2%	$4.2B+1.5%	$4.1B+2.1%	$4.0B
Retained Earnings	N/A	N/A	N/A	$7.4B	N/A	N/A	$7.0B	N/A

JBHT Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$1.5B-15.0%	$1.7B-1.8%	$1.8B+45.2%	$1.2B+9.0%	$1.1B+2.2%	$1.1B
Capital Expenditures	$865.4M-53.5%	$1.9B+20.9%	$1.5B+62.6%	$947.6M+28.3%	$738.5M-13.5%	$854.1M
Free Cash Flow	$617.8M+624.4%	-$117.8M-149.9%	$236.1M-14.6%	$276.3M-28.1%	$384.3M+57.4%	$244.2M
Investing Cash Flow	-$663.7M+60.6%	-$1.7B-8.7%	-$1.6B-76.7%	-$877.0M-43.1%	-$613.0M+23.8%	-$804.0M
Financing Cash Flow	-$825.8M-1324.2%	-$58.0M+89.1%	-$530.4M-74.1%	-$304.6M-31.5%	-$231.6M+13.3%	-$267.0M
Dividends Paid	$175.5M+0.9%	$173.9M+4.3%	$166.7M+34.0%	$124.4M+8.9%	$114.2M+2.2%	$111.8M
Share Buybacks	$513.9M+222.1%	$159.6M-46.8%	$300.0M+97.8%	$151.7M+63.9%	$92.5M-66.4%	$275.7M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$486.4M+21.0%	$402.1M-0.5%	$404.2M+27.3%	$317.6M-11.9%	$360.6M-22.7%	$466.5M+117.0%	$215.0M-50.3%	$432.3M
Capital Expenditures	$134.1M-38.1%	$216.5M-11.9%	$245.8M+9.6%	$224.3M-14.5%	$262.3M+29.0%	$203.4M-33.1%	$303.8M-39.2%	$499.6M
Free Cash Flow	$352.4M+89.9%	$185.6M+17.2%	$158.4M+69.7%	$93.3M-5.0%	$98.2M-62.7%	$263.1M+396.1%	-$88.8M-32.0%	-$67.3M
Investing Cash Flow	-$91.8M+47.2%	-$174.0M+22.7%	-$225.1M-20.9%	-$186.2M+23.3%	-$242.7M-49.4%	-$162.4M+42.1%	-$280.3M+49.1%	-$551.1M
Financing Cash Flow	-$393.2M-78.3%	-$220.5M-20.7%	-$182.7M+10.6%	-$204.5M-59.0%	-$128.6M+56.2%	-$293.2M-774.9%	$43.5M+142.6%	-$101.9M
Dividends Paid	$42.5M-0.3%	$42.6M-3.1%	$44.0M+1.3%	$43.4M-1.3%	$44.0M-0.9%	$44.4M+2.5%	$43.4M-0.2%	$43.4M
Share Buybacks	$230.4M-27.7%	$318.8M+36.2%	$234.1M+173.4%	$85.6M-57.8%	$203.1M+708.1%	$25.1M+2.4%	$24.5M-52.0%	$51.1M

JBHT Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	6.9%-0.9pp	7.7%-1.2pp	9.0%+0.4pp	8.6%+1.2pp	7.4%-0.6pp	8.0%
Net Margin	4.7%-1.0pp	5.7%-0.9pp	6.5%+0.3pp	6.3%+1.0pp	5.3%-0.4pp	5.6%
Return on Equity	14.2%-3.5pp	17.8%-8.7pp	26.4%+2.0pp	24.4%+4.9pp	19.5%-3.3pp	22.8%
Return on Assets	6.9%-1.6pp	8.5%-4.0pp	12.4%+1.2pp	11.2%+2.7pp	8.5%-0.9pp	9.4%
Current Ratio	1.06-0.3	1.35-0.1	1.41+0.1	1.34-0.4	1.70+0.3	1.43
Debt-to-Equity	0.24-0.1	0.32-0.0	0.34+0.0	0.30-0.2	0.50-0.1	0.57
FCF Margin	5.1%+6.0pp	-0.9%-2.5pp	1.6%-0.7pp	2.3%-1.7pp	4.0%+1.3pp	2.7%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	8.0%+1.2pp	6.7%+0.6pp	6.1%-0.5pp	6.6%-0.4pp	7.0%+0.4pp	6.6%+0.5pp	6.2%-1.5pp	7.6%
Net Margin	5.6%+1.2pp	4.4%+0.4pp	4.0%-0.9pp	4.9%+0.3pp	4.6%+0.3pp	4.3%-0.3pp	4.7%-1.3pp	5.9%
Return on Equity	4.8%+1.3pp	3.5%+0.5pp	3.0%-0.8pp	3.9%+0.5pp	3.3%+0.3pp	3.1%-0.7pp	3.7%-0.9pp	4.7%
Return on Assets	2.1%+0.6pp	1.6%+0.1pp	1.4%-0.4pp	1.9%+0.3pp	1.6%+0.1pp	1.5%-0.3pp	1.8%-0.5pp	2.2%
Current Ratio	0.870.0	0.87-0.0	0.89-0.2	1.06-0.2	1.21-0.1	1.26-0.1	1.35+0.2	1.11
Debt-to-Equity	0.25-0.0	0.28+0.1	0.23-0.0	0.24-0.1	0.36+0.0	0.330.0	0.32+0.0	0.30
FCF Margin	11.5%+5.2pp	6.3%+0.9pp	5.4%+2.4pp	3.0%-0.4pp	3.4%-5.6pp	8.9%+11.6pp	-2.7%-0.6pp	-2.1%

Similar Companies

C H Robinson Worldwide Inc CHRW

$20.8B

$19.6B

$18.9B

$88.1B

$101.2B

Frequently Asked Questions

What is JB Hunt Trans's annual revenue?

JB Hunt Trans (JBHT) reported $12.1B in total revenue for fiscal year 2024. This represents a -5.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JB Hunt Trans's revenue growing?

JB Hunt Trans (JBHT) revenue declined by 5.8% year-over-year, from $12.8B to $12.1B in fiscal year 2024.

Is JB Hunt Trans profitable?

Yes, JB Hunt Trans (JBHT) reported a net income of $570.9M in fiscal year 2024, with a net profit margin of 4.7%.

What is JB Hunt Trans's earnings per share (EPS)?

JB Hunt Trans (JBHT) reported diluted earnings per share of $5.56 for fiscal year 2024. This represents a -20.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is JB Hunt Trans's EBITDA?

JB Hunt Trans (JBHT) had EBITDA of $1.6B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does JB Hunt Trans have?

As of fiscal year 2024, JB Hunt Trans (JBHT) had $47.0M in cash and equivalents against $977.7M in long-term debt.

What is JB Hunt Trans's operating margin?

JB Hunt Trans (JBHT) had an operating margin of 6.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is JB Hunt Trans's net profit margin?

JB Hunt Trans (JBHT) had a net profit margin of 4.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does JB Hunt Trans pay dividends?

Yes, JB Hunt Trans (JBHT) paid $1.72 per share in dividends during fiscal year 2024.

What is JB Hunt Trans's return on equity (ROE)?

JB Hunt Trans (JBHT) has a return on equity of 14.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is JB Hunt Trans's free cash flow?

JB Hunt Trans (JBHT) generated $617.8M in free cash flow during fiscal year 2024. This represents a 624.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is JB Hunt Trans's operating cash flow?

JB Hunt Trans (JBHT) generated $1.5B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are JB Hunt Trans's total assets?

JB Hunt Trans (JBHT) had $8.3B in total assets as of fiscal year 2024, including both current and long-term assets.

What are JB Hunt Trans's capital expenditures?

JB Hunt Trans (JBHT) invested $865.4M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does JB Hunt Trans buy back shares?

Yes, JB Hunt Trans (JBHT) spent $513.9M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does JB Hunt Trans have outstanding?

JB Hunt Trans (JBHT) had 101M shares outstanding as of fiscal year 2024.

What is JB Hunt Trans's current ratio?

JB Hunt Trans (JBHT) had a current ratio of 1.06 as of fiscal year 2024, which is considered adequate.

What is JB Hunt Trans's debt-to-equity ratio?

JB Hunt Trans (JBHT) had a debt-to-equity ratio of 0.24 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JB Hunt Trans's return on assets (ROA)?

JB Hunt Trans (JBHT) had a return on assets of 6.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is JB Hunt Trans's Altman Z-Score?

JB Hunt Trans (JBHT) has an Altman Z-Score of 5.97, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is JB Hunt Trans's Piotroski F-Score?

JB Hunt Trans (JBHT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JB Hunt Trans's earnings high quality?

JB Hunt Trans (JBHT) has an earnings quality ratio of 2.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can JB Hunt Trans cover its interest payments?

JB Hunt Trans (JBHT) has an interest coverage ratio of 10.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is JB Hunt Trans?

JB Hunt Trans (JBHT) scores 42 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.